PubRank

L Turski

Author PubWeight™ 83.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999 6.37
2 Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 1983 2.46
3 Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000 2.34
4 Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A 2001 1.88
5 Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res 1984 1.59
6 Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci 1989 1.57
7 Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1992 1.57
8 Glutamate: a new target in schizophrenia? Trends Pharmacol Sci 1990 1.43
9 Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A 2000 1.21
10 The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res 1987 1.20
11 N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A 1999 1.20
12 Cholinomimetics produce seizures and brain damage in rats. Experientia 1983 1.18
13 NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol 1990 1.11
14 Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006 1.04
15 Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. Proc Natl Acad Sci U S A 1997 1.01
16 Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci U S A 1993 1.00
17 Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience 1986 0.99
18 Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport 1996 0.96
19 The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Ann Neurol 1991 0.94
20 Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J Pharmacol Exp Ther 1990 0.94
21 Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 1994 0.93
22 Muscle relaxant action of excitatory amino acid antagonists. Neurosci Lett 1985 0.92
23 Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res 1987 0.92
24 Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. J Pharmacol Exp Ther 1993 0.91
25 Excitotoxicity and neurodegenerative diseases. Curr Opin Neurol 1995 0.90
26 Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A 1987 0.89
27 Convulsant action of morphine, [D-Ala2, D-Leu5]-enkephalin and naloxone in the rat amygdala: electroencephalographic, morphological and behavioural sequelae. Neuroscience 1987 0.88
28 Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res 1986 0.87
29 Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation. Psychopharmacol Ser 1993 0.87
30 Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or gamma-vinyl-GABA into the substantia nigra. Brain Res 1986 0.86
31 Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Proc Natl Acad Sci U S A 1996 0.86
32 Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. J Neural Transm Park Dis Dement Sect 1991 0.85
33 Long-term treatment with abecarnil does not induce diazepam-like dependence in mice. J Pharmacol Exp Ther 1993 0.84
34 Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience 1985 0.84
35 Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit Rev Neurobiol 1996 0.84
36 Intrahippocampal bethanechol in rats: behavioural, electroencephalographic and neuropathological correlates. Behav Brain Res 1983 0.82
37 Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats. Brain Res 1986 0.82
38 Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation. Life Sci 1983 0.82
39 Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio. Naunyn Schmiedebergs Arch Pharmacol 1986 0.81
40 Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eur J Pharmacol 1996 0.81
41 Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats. Brain Res 1988 0.81
42 Effects of some antiepileptic drugs in pentetrazol-induced convulsions in mice lesioned with kainic acid. Epilepsia 1981 0.81
43 Effects of morphine and naloxone on pilocarpine-induced convulsions in rats. Neuropeptides 1985 0.81
44 Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine. Brain Res 1988 0.81
45 Kindling to the benzodiazepine receptor inverse agonist, FG 7142: evidence for involvement of NMDA, but not non-NMDA, glutamatergic receptors. Neuropharmacology 1993 0.81
46 Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab Brain Dis 1996 0.80
47 Role of muscarinic cholinergic mechanisms in the substantia nigra pars reticulata in mediating muscular rigidity in rats. Naunyn Schmiedebergs Arch Pharmacol 1984 0.80
48 Evidence that antagonism at non-NMDA receptors results in anticonvulsant action. Eur J Pharmacol 1987 0.80
49 Studies on the mechanism of wet dog shakes produced by carbachol in rats. Pharmacology 1984 0.80
50 Reversal of the muscle relaxant effect of diazepam but not of progabide by a specific benzodiazepine antagonist: Ro 15-1788. Eur J Pharmacol 1983 0.79
51 MPTP-induced degeneration: interference with glutamatergic toxicity. J Neural Transm Suppl 1994 0.79
52 Neurochemical changes in the hippocampus of rats with spontaneous recurrent seizures. Epilepsy Res Suppl 1992 0.79
53 Anticonvulsant action of phenobarbital, diazepam, carbamazepine, and diphenylhydantoin in the electroshock test in mice after lesion of hippocampal pyramidal cells with intracerebroventricular kainic acid. Epilepsia 1982 0.79
54 Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist? Brain Res 1985 0.79
55 Anticonvulsant action of stereoisomers of gamma-glutamylaminomethylsulphonic acid in mice. Eur J Pharmacol 1985 0.79
56 Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: morphological and electroencephalographic correlates. Brain Res 1985 0.79
57 Is the muscle relaxant effect of diazepam in spastic mutant rats mediated through GABA-independent benzodiazepine receptors? Neurosci Lett 1983 0.78
58 Nigral GABAergic mechanisms and EMG activity in rats: differences between pars reticulata and pars compacta. Eur J Pharmacol 1983 0.78
59 Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann Neurol 1993 0.78
60 Delta-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system. Exp Brain Res 1988 0.78
61 The rat ventromedial thalamic nucleus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission. J Neurosci 1986 0.78
62 Pharmacology of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo-(F)-quinoxaline. Ann N Y Acad Sci 1997 0.78
63 Role of opioid receptors in the substantia nigra in morphine-induced muscular rigidity. Life Sci 1983 0.78
64 Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systems. Psychopharmacology (Berl) 1980 0.78
65 Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents. Neurosci Lett 1987 0.77
66 Interaction between phenytoin and diazepam in mutant Han-Wistar rats with progressive spastic paresis. Naunyn Schmiedebergs Arch Pharmacol 1982 0.77
67 ZK 91296, an anticonvulsant beta-carboline which lacks muscle relaxant properties. Eur J Pharmacol 1985 0.77
68 What are the differences between abecarnil and conventional benzodiazepine anxiolytics? Adv Biochem Psychopharmacol 1992 0.77
69 Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleus. Brain Res 1986 0.77
70 Effect of aminophylline on muscle relaxant action of diazepam and phenobarbitone in genetically spastic rats: further evidence for a purinergic mechanism in the action of diazepam. Eur J Pharmacol 1984 0.77
71 A specific benzodiazepine antagonist CGS 8216 reverses the muscle relaxant effect of diazepam but not that of phenobarbitone. Eur J Pharmacol 1984 0.77
72 Anticonvulsant activity of two novel piperazine derivatives with potent kainate antagonist activity. Neurosci Lett 1985 0.76
73 Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats. Psychopharmacology (Berl) 1981 0.76
74 Anticonvulsant role of adenosine. Pol J Pharmacol Pharm 1989 0.76
75 Microinjections of the gamma-aminobutyrate antagonist, bicuculline methiodide, into the caudate-putamen prevent amygdala-kindled seizures in rats. Brain Res 1987 0.76
76 Kainic acid-induced wet dog shakes in rats. The relation to central neurotransmitters. Naunyn Schmiedebergs Arch Pharmacol 1980 0.76
77 Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex. Exp Brain Res 1988 0.76
78 The involvement of catecholaminergic mechanisms in the appearance of wet dog shakes produced by carbachol chloride in rats. Arch Int Pharmacodyn Ther 1982 0.76
79 Studies of carbachol-induced wet-dog shake behavior in rats. Psychopharmacology (Berl) 1981 0.76
80 Rigidity and catalepsy after injections of muscimol into the ventromedial thalamic nucleus: an electromyographic study in the rat. Exp Brain Res 1985 0.76
81 (RS)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: wet dog shakes, catalepsy and body temperature changes in rats. Pharmacol Biochem Behav 1981 0.76
82 Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Synapse 1990 0.75
83 Evaluation of the muscle relaxant properties of a novel beta-carboline, ZK 93423 in rats and cats. Br J Pharmacol 1985 0.75
84 Effects of the antiparkinsonian drug budipine on central neurotransmitter systems. Eur J Pharmacol 1996 0.75
85 Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX. Neurosci Lett 1992 0.75
86 Intraamygdaloid morphine produces seizures and brain damage in rats. Life Sci 1983 0.75
87 Effects of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures. Arch Int Pharmacodyn Ther 1985 0.75
88 The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra. Neuropharmacology 1983 0.75
89 Dyphenylhydantoin enhancement of diazepam effects on locomotor activity in mice. Psychopharmacology (Berl) 1982 0.75
90 Diphenylhydantoin potentiates the protective effect of diazepam against pentylenetetrazol but not against bicuculline and isoniazid-induced seizures in mice. Neuropharmacology 1981 0.75
91 Reversal of the muscle relaxant effect of diazepam by the specific benzodiazepine antagonist Ro 15-1788: an electromyographic study in morphine model of muscular rigidity in rats. Life Sci 1983 0.75
92 [The influence of atropine on the antiamphetaminic action of fluphenazine (author's transl)]. Ann Univ Mariae Curie Sklodowska Med 1979 0.75
93 Myorelaxant effect after intrathecal injection of antispastic drugs in rats. Neurosci Lett 1989 0.75
94 The threshold for limbic seizures in rats is decreased by intranigral morphine. NIDA Res Monogr 1986 0.75
95 Effects of morphine, nalorphine and morphine withdrawal on lethal toxicity of intracerebroventricular kainic acid in mice. Pol J Pharmacol Pharm 1981 0.75
96 Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine. Brain Res 1986 0.75
97 On the possible role of excitatory amino acids in the striatum in mediating morphine-induced muscular rigidity. Pharmacol Biochem Behav 1982 0.75
98 Disturbed GABAergic transmission in mutant Han-Wistar rats: further evidence for basal ganglia dysfunction. Brain Res 1985 0.75
99 Distinct sites of functional interaction between dopamine, acetylcholine and gamma-aminobutyrate within the neostriatum: an electromyographic study in rats. Neuroscience 1986 0.75
100 Effects of morphine and nalorphine on kainic acid-induced hypothermia in rats. Psychopharmacology (Berl) 1981 0.75
101 Does morphine withdrawal produce brain damage in rats? Life Sci 1983 0.75
102 GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: differences between dorsal and ventral striatum. Brain Res 1984 0.75
103 Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity in rats. Neurosci Lett 1982 0.75
104 The locomotor and exploratory activities in rats after lesion of hippocampal pyramidal cells with kainic acid. Pol J Pharmacol Pharm 1981 0.75
105 Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice. Neurosci Res 1985 0.75
106 Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1987 0.75
107 Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 1986 0.75
108 The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist. J Neural Transm Park Dis Dement Sect 1993 0.75
109 Role of GABAergic mechanisms in the substantia nigra pars reticulata in modulating morphine-induced muscular rigidity in rats. Neurosci Lett 1982 0.75
110 Effect of combined treatment of phenytoin with diazepam on the susceptibility of mice to electroconvulsions. J Pharm Pharmacol 1981 0.75
111 Prevention of kainic acid-induced seizure-like activity by antiepileptic drugs. Pol J Pharmacol Pharm 1981 0.75
112 Induction of wet dog shakes by intracerebroventricular bethanechol in rats. Antagonism by neurotransmitter receptor blockers. Pharmacology 1982 0.75
113 Excitatory amino acids--quo vadis? Braz J Med Biol Res 1989 0.75
114 Effect of antidepressant drugs on carbachol chloride-induced wet dog shake behaviour in rats. Neuropharmacology 1981 0.75
115 Effect of glutamic acid diethylester on (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and kainic acid-induced changes of body temperature in rats. Pol J Pharmacol Pharm 1982 0.75
116 Muscle relaxant action of phenobarbitone in genetically spastic rats: an electromyographic study. Eur J Pharmacol 1986 0.75
117 The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats. Pol J Pharmacol Pharm 1982 0.75
118 Biochemical consequences of kainic acid injection into the lateral brain ventricle in rat. Acta Biochim Pol 1981 0.75
119 Effects of combined treatment with diphenylhydantoin and different benzodiazepines on pentylenetetrazol- and bicuculline-induced seizures in mice. Neuropharmacology 1982 0.75
120 Unusual interactions of excitatory amino acid receptor agonists: alpha- and beta-kainate antagonize motor responses to N-methyl-D-aspartate in rodents. Neuroscience 1987 0.75
121 Shuttle behavior in rats after lesion of hippocampal pyramidal cells with kainic acid. Methods Find Exp Clin Pharmacol 1982 0.75
122 Convulsant action of naloxone in the rat amygdala. NIDA Res Monogr 1986 0.75
123 Muscle relaxant action of 2-chloroadenosine in genetically spastic rats is independent of gamma-aminobutyric acid-mediated inhibition. Neurosci Lett 1985 0.75
124 Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice. Eur J Pharmacol 1984 0.75
125 Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy. Methods Find Exp Clin Pharmacol 1982 0.75
126 Convulsant action of pentetrazol in rats with selective lesions of the hippocampal pyramidal cells with intracerebroventricular kainic acid. Methods Find Exp Clin Pharmacol 1982 0.75
127 Effect of trazodone, mianserin, iprindole and zimelidine on wet dog shakes produced by carbachol in rats. J Pharm Pharmacol 1981 0.75
128 The role of striatal cholinergic mechanisms for the development of limb rigidity: an electromyographic study in rats. Brain Res 1986 0.75
129 Atropine reversal of kainic acid-induced decrease in the leptazol convulsive threshold. J Pharm Pharmacol 1981 0.75
130 CGS 8216, Ro 15-1788 and methyl-beta-carboline-3-carboxylate, but not EMD 41717 antagonize the muscle relaxant effect of diazepam in genetically spastic rats. Life Sci 1984 0.75
131 Effects of methyl beta-carboline-3-carboxylate, Ro 15-1788 and CGS 8216 on muscle tone in genetically spastic rats. Eur J Pharmacol 1985 0.75
132 Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways. Behav Brain Res 1982 0.75
133 Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction? Behav Brain Res 1984 0.75
134 Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems. Neuropharmacology 1985 0.75
135 Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 1986 0.75